Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Daytrana (Methylphenidate Transdermal System	37
Overall Study	STARTED	Vyvanse (Lisdexamfetamine Dimesylate)	76
Overall Study	STARTED	Concerta (Osmotic-release Oral System Methylphenidate)	67
Overall Study	STARTED	Adderall (Mixed Amphetamine Salts Extended Release)	48
Overall Study	COMPLETED	Daytrana (Methylphenidate Transdermal System	35
Overall Study	COMPLETED	Vyvanse (Lisdexamfetamine Dimesylate)	71
Overall Study	COMPLETED	Concerta (Osmotic-release Oral System Methylphenidate)	54
Overall Study	COMPLETED	Adderall (Mixed Amphetamine Salts Extended Release)	40
Overall Study	NOT COMPLETED	Daytrana (Methylphenidate Transdermal System	2
Overall Study	NOT COMPLETED	Vyvanse (Lisdexamfetamine Dimesylate)	5
Overall Study	NOT COMPLETED	Concerta (Osmotic-release Oral System Methylphenidate)	13
Overall Study	NOT COMPLETED	Adderall (Mixed Amphetamine Salts Extended Release)	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00889915/flow